These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38962322)
1. Molecular characterization of carbapenem and ceftazidime-avibactam-resistant Enterobacterales and horizontal spread of Sobh G; Araj GF; Finianos M; Sourenian T; Hrabak J; Pappagianitsis CC; Chaar ME; Bitar I Front Cell Infect Microbiol; 2024; 14():1407246. PubMed ID: 38962322 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli. Öztaş S; Er DK; Dündar D; Keçeli SA Acta Microbiol Immunol Hung; 2024 Jul; 71(2):110-120. PubMed ID: 38837219 [TBL] [Abstract][Full Text] [Related]
3. Ceftazidime-avibactam activity against a challenge set of carbapenem-resistant Enterobacterales: Ompk36 L3 alterations and β-lactamases with ceftazidime hydrolytic activity lead to elevated MIC values. Castanheira M; Doyle TB; Hubler C; Sader HS; Mendes RE Int J Antimicrob Agents; 2020 Jul; 56(1):106011. PubMed ID: 32417206 [TBL] [Abstract][Full Text] [Related]
4. Emergence of ceftazidime-avibactam resistance in bla Zhou J; Yan G; Tang C; Liu J; Fu P; Ding L; Yang W; Guo Y; Wang C; Lu G; Hu F Int J Antimicrob Agents; 2024 Jun; 63(6):107163. PubMed ID: 38570018 [TBL] [Abstract][Full Text] [Related]
5. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring Niu S; Chavda KD; Wei J; Zou C; Marshall SH; Dhawan P; Wang D; Bonomo RA; Kreiswirth BN; Chen L mSphere; 2020 Aug; 5(4):. PubMed ID: 32848008 [TBL] [Abstract][Full Text] [Related]
8. Ceftazidime-Avibactam resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae: A phenotypic and genotypic analysis. Krithika VM; Ganesan V; Rajendran T Indian J Med Microbiol; 2024; 49():100603. PubMed ID: 38705276 [TBL] [Abstract][Full Text] [Related]
9. Acquisition of a Stable and Transferable Huang J; Zhang S; Zhao Z; Chen M; Cao Y; Li B Front Cell Infect Microbiol; 2021; 11():658070. PubMed ID: 34354959 [TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms Driving the Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448 [TBL] [Abstract][Full Text] [Related]
11. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201 [TBL] [Abstract][Full Text] [Related]
12. Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitals. Castanheira M; Doyle TB; Deshpande LM; Mendes RE; Sader HS Int J Antimicrob Agents; 2021 Nov; 58(5):106439. PubMed ID: 34547421 [TBL] [Abstract][Full Text] [Related]
13. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae. Venditti C; Butera O; Meledandri M; Balice MP; Cocciolillo GC; Fontana C; D'Arezzo S; De Giuli C; Antonini M; Capone A; Messina F; Nisii C; Di Caro A Clin Microbiol Infect; 2021 Jul; 27(7):1040.e1-1040.e6. PubMed ID: 33775814 [TBL] [Abstract][Full Text] [Related]
16. Dissemination of the Tian D; Wang B; Zhang H; Pan F; Wang C; Shi Y; Sun Y mSphere; 2020 Jan; 5(1):. PubMed ID: 31915216 [TBL] [Abstract][Full Text] [Related]
17. Emergence of NDM-producing Klebsiella pneumoniae and Escherichia coli in Spain: phylogeny, resistome, virulence and plasmids encoding blaNDM-like genes as determined by WGS. Pérez-Vázquez M; Sola Campoy PJ; Ortega A; Bautista V; Monzón S; Ruiz-Carrascoso G; Mingorance J; González-Barberá EM; Gimeno C; Aracil B; Sáez D; Lara N; Fernández S; González-López JJ; Campos J; Kingsley RA; Dougan G; Oteo-Iglesias J; J Antimicrob Chemother; 2019 Dec; 74(12):3489-3496. PubMed ID: 31504589 [TBL] [Abstract][Full Text] [Related]
18. Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Wu Y; Yu W; Chu X; Zhang J; Jia P; Liu X; Zhu Y; Xu Y; Yang Q Microbiol Spectr; 2024 Jun; 12(6):e0010724. PubMed ID: 38712934 [TBL] [Abstract][Full Text] [Related]
19. Longitudinal Genomic Characterization of Carbapenemase-producing Enterobacteriaceae (CPE) Reveals Changing Pattern of CPE Isolated in Hong Kong Hospitals. Zhu C; Li C; Lai CKC; Ng R; Chau KY; Wong KT; Lo NWS; Barua N; Yang Y; Liyanapathirana V; Hui M; Lai RW; Fung KSC; Tsang DN; Ip M Int J Antimicrob Agents; 2021 Nov; 58(5):106430. PubMed ID: 34525401 [TBL] [Abstract][Full Text] [Related]
20. Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates. Benulič K; Pirš M; Couto N; Chlebowicz M; Rossen JWA; Zorec TM; Seme K; Poljak M; Lejko Zupanc T; Ružić-Sabljić E; Cerar T PLoS One; 2020; 15(4):e0231503. PubMed ID: 32282829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]